Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-κB inhibitor, through downregulation of NFATc1

被引：136

作者：

Takatsuna, H

Asagiri, M

Kubota, T

Oka, K

Osada, T

Sugiyama, C

Saito, H

Aoki, K

Ohya, K

Takayanagi, H

Umezawa, K

机构：

[1] Keio Univ, Dept Appl Chem, Fac Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2230061, Japan

[2] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Grad Sch, Tokyo, Japan

[3] Tokyo Med & Dent Univ, COE Program Frontier Res Mol Destruct & Reconstru, Grad Sch, Tokyo, Japan

[4] Keio Univ, Dept Biosci & Infomat, Fac Sci & Technol, Yokohama, Kanagawa 223, Japan

[5] Tokyo Med & Dent Univ, Dept Hard Tissue Engn, Grad Sch, Tokyo, Japan

[6] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Kawaghuchi, Japan

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 04期

关键词：

NF-kappa B; RANKL; NFATc1; osteoclastogenesis; bone resorption;

D O I：

10.1359/JBMR.041213

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

(-)-DHMEQ, a newly designed NF-kappa B inhibitor, inhibited RANKL-induced osteoclast differentiation in mouse BMMs through downregulation of the induction of NFATc1, an essential transcription factor of osteoclastogenesis.

引用

页码：653 / 662

页数：10

共 50 条

[1] Inhibition of NFATc1 expression and RANKL-induced osteoclast differentiation by (-)-DHMEQ, a specific inhibitor of NF-κB
Osada, T
Takatsuna, H
Ogura, H
Umezawa, K
FASEB JOURNAL, 2005, 19 (04): : A277 - A277
[2] Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways
Zhu, Mengbo
Xu, Wenbin
Jiang, Jiuzhou
Wang, Yining
Guo, Yanjing
Yang, Ruijia
Chang, Yaqiong
Zhao, Bin
Wang, Zhenyu
Zhang, Jianfeng
Wang, Te
Shangguan, Liqin
Wang, Shaowei
FRONTIERS IN ENDOCRINOLOGY, 2021, 12
[3] Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1
Peng, Qiuyue
Luo, Aishu
Zhou, Zihao
Xuan, Wenhua
Qiu, Ming
Wu, Qin
Xu, Lingxiao
Kong, Xiangqing
Zhang, Miaojia
Tan, Wenfeng
Xue, Meilang
Wang, Fang
CYTOKINE, 2019, 113 : 144 - 154
[4] Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways
Nepal, Manoj
Choi, Hwa Jung
Choi, Bo-Yun
Yang, Moon-Shik
Chae, Jung-Il
Li, Liang
Soh, Yunjo
EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 715 (1-3) : 96 - 104
[5] Pim-1 Regulates RANKL-Induced Osteoclastogenesis via NF-κB Activation and NFATc1 Induction
Kim, Kabsun
Kim, Jung Ha
Youn, Bang Ung
Jin, Hye Mi
Kim, Nacksung
JOURNAL OF IMMUNOLOGY, 2010, 185 (12): : 7460 - 7466
[6] Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation
Tsuji-Naito, Kentaro
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (20) : 9176 - 9183
[7] Asiaticoside, a component of Centella asiatica attenuates RANKL-induced osteoclastogenesis via NFATc1 and NF-κB signaling pathways
He, Lilei
Hong, Guoju
Zhou, Lin
Zhang, Jianguo
Fang, Jian
He, Wei
Tickner, Jennifer
Han, Xiaorui
Zhao, Lilian
Xu, Jiake
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) : 4267 - 4276
[8] Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
Min-Kyoung Song
Zang Hee Lee
Hong-Hee Kim
Experimental & Molecular Medicine, 2015, 47 : e199 - e199
[9] Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
Song, Min-Kyoung
Lee, Zang Hee
Kim, Hong-Hee
EXPERIMENTAL AND MOLECULAR MEDICINE, 2015, 47 : e199 - e199
[10] Lanthanum Chloride Attenuates Osteoclast Formation and Function Via the Downregulation of Rankl-Induced Nf-κb and Nfatc1 Activities
Jiang, Chuan
Shang, Jiangyinzi
Li, Zhe
Qin, An
Ouyang, Zhengxiao
Qu, Xinhua
Li, Haowei
Tian, Bo
Wang, Wengang
Wu, Chuanlong
Wang, Jinwu
Dai, Min
JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (01) : 142 - 151

← 1 2 3 4 5 →